Short Description

The Quadruple test is used for Prenatal Screening of Down Syndrome (Trisomy 21), Edwardƒ??s Syndrome (Trisomy 18) and Open Neural Tube Defects. The approximate detection rate with this test is 75-80 % with a false positive rate of 5%.

PreTest Information

Provide maternal Date of birth (dd/mm/yy); LMP or Ultrasound; IVF, Number of Fetuses (Single/ Twins); Diabetic status and Body Weight in Kg, Smoking & Previous history of Trisomy 21 pregnancy. Duly filled Maternal Serum Screen requisition form (Form 11) is mandatory. Valid between 14-22 weeks gestation (Ideal 15-20 weeks).

Detail Description

MATERNAL SERUM SCREEN 4 QUADRUPLE TEST

Maternal Serum Screen 4 Quadruple Test is a prenatal test that is performed on pregnant women to determine the likelihood of certain birth defects in their babies. The test measures the levels of four substances in the mother's blood: alpha-fetoprotein (AFP), human chorionic gonadotropin (HCG), estriol, and inhibin A. The test is usually done between the 15th and 20th week of pregnancy.

Test Cost

The cost of the Maternal Serum Screen 4 Quadruple Test in India is INR 4500.

Symptoms

There are no specific symptoms for which the Maternal Serum Screen 4 Quadruple Test is recommended. However, the test is usually offered to women who are at increased risk of having a baby with certain birth defects, such as Down syndrome, neural tube defects, or other chromosomal abnormalities. Women who are over 35 years of age, have a family history of these conditions, or have had a previous pregnancy with a birth defect are usually considered at increased risk.

Diagnosis

The Maternal Serum Screen 4 Quadruple Test is not a diagnostic test, but rather a screening test. This means that it can indicate whether a woman is at increased risk of having a baby with certain birth defects, but it cannot diagnose these conditions with certainty. If the test results suggest an increased risk, further diagnostic tests, such as amniocentesis or chorionic villus sampling, may be recommended to confirm the diagnosis.

Conclusion

The Maternal Serum Screen 4 Quadruple Test is an important prenatal test that can help identify the risk of certain birth defects in the baby. If you are pregnant and are considered at increased risk of these conditions, talk to your doctor about whether this test is right for you. The cost of the test in India is INR 4500, and it is usually performed between the 15th and 20th week of pregnancy.

Remember, early detection and diagnosis of birth defects can lead to better outcomes for both the mother and the baby. So, don't hesitate to ask your doctor about prenatal testing options that may be appropriate for you.

For more information on prenatal testing and other healthcare services, visit DNA Labs India.